Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > 1 gap at .085

<< Previous

Bullboard Posts

Next >>

Comment by 92kaneon Jul 25, 2018 6:48am

104 Views

Post# 28363099

RE:RE:RE:1 gap at .085

The 19th and 20th of june have a gap between the closing price, on the 19th and opening price on the 20th. The stock wasn't an actual gap though as it went higher and lower on each day filling in between but this is the only place i can see a connection. Hmm

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks